BAK Immune Cell Therapy: Precision Strike Against HLA-I Negative Cancer Cells
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
BAK therapy (BRM Activated Killer) is an advanced immune cell treatment technology focused on the large-scale activation and proliferation of "CD56-positive cells" within a patient's body. The most significant feature of this therapy is the breadth of its attack, particularly against "invisible" cancer cells that can evade conventional T-cell strikes.
Core Principles of BAK Therapy
Traditional CTL (Cytotoxic T Lymphocyte) and Dendritic Cell (DC) therapies rely heavily on HLA-I (Major Histocompatibility Complex Class I) molecules on the surface of cancer cells for identification. However, many advanced cancer cells evolve mechanisms to reduce or stop the expression of HLA-I, thereby escaping T-cell detection.
BAK therapy overcomes this challenge through the following mechanisms:
- Activation of CD56-Positive Cells: Primarily proliferates NK cells and γδ T cells, which can identify and kill foreign substances without relying on HLA-I.
- Comprehensive Attack: In addition to NK and γδ T cells, the culture process includes CTLs and helper T cells, forming a multi-dimensional immune army.
- High Proliferation Rate: Using the patented serum-free AlyS-BAK culture medium, cell counts can be safely expanded to 10 billion, significantly increasing the offensive firepower.
Patented Technology and Safety
- Patented Culture Medium: The AlyS-BAK culture medium does not contain human or animal serum, completely eliminating the risk of infection from exogenous viruses or bacteria and ensuring high safety during the treatment process.
- Enhanced Offensive Power: Induction by cytokines such as IFN-α and IL-2 significantly enhances the ability of immune cells to penetrate and destroy tumor tissue.
Medical Institution: Akasaka AA Clinic (Tokyo)
BAK therapy is primarily implemented at the "Akasaka AA Clinic," located in a prime area of Minato-ku, Tokyo. The clinic is led by renowned personalized medicine experts and provides comprehensive cancer support and quality-of-life improvements by combining tumor immunotherapy with high-dose Vitamin C and ozone therapy.
[Medical Supporter Compliance Statement] Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.